Trastuzumab emtansine for HER2-positive metastatic breast cancer: Outcomes from a whole-of-population Australian cohort

Daniels, B; Kiely, BE; Tang, MI; Houssami, N; Lord, SJ; Pearson, SA

Daniels, B (corresponding author), UNSW, Medicines Policy Res Unit, Ctr Big Data Res Hlth, Sydney, NSW, Australia.; Daniels, B (corresponding author), AGSM Bldg,Level 2, Kensington, NSW 2052, Australia.

BREAST, 2021; 58 (): 106

Abstract

Purpose: We aim to describe the treatment patterns and overall survival (OS) outcomes in patients receiving trastuzumab emtansine (T-DM1) for HER2-pos......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索